Pasar al contenido principal

BASE BIOLOGICA DE LA MODIFICACION DEL RIESGO DE CANCER DE MAMA: HACIA LA MEJORA DE LA PREVENCIÓN

PI21/01306

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2021
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION IDIBELL
Centro realización INSTITUTO DE INVESTIGACION BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival

  • Minguillón Pedreño, Jordi|||0000-0003-2124-8294
  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
  • Rovirosa Mulet, Llorenç|||0000-0003-2986-9001
  • Bustamante-Madrid, Pilar|||0000-0003-4540-9742
  • Camps-Fajol, Cristina
  • Ruiz de Garibay, Gorka|||0000-0001-9936-8419
  • Shimelis, Hermela
  • Montanuy Escribano, Helena
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Hernández Viedma, Gonzalo|||0000-0002-3048-9607
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Castillo, Pau
  • Soucy, Penny
  • Martrat, Griselda
  • Gómez Moruno, Antonio|||0000-0001-5308-981X
  • Cuadras, Daniel|||0000-0001-8780-1764
  • García, María J.
  • Gayarre, Javier|||0000-0003-0377-6712
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Benitez, Javier|||0000-0002-0923-7202
  • Couch, Fergus J.
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Surralles, Jordi|||0000-0002-4041-7519
BRCA2 is essential for homologous recombination DNA repair. BRCA2 mutations lead to genome instability and increased risk of breast and ovarian cancer. Similarly, mutations in BRCA2-interacting proteins are also known to modulate sensitivity to DNA damage agents and are established cancer risk factors. Here we identify the tumor suppressor CDK5RAP3 as a novel BRCA2 helical domain-interacting protein. CDK5RAP3 depletion induced DNA damage resistance, homologous recombination and single-strand annealing upregulation, and reduced spontaneous and DNA damage-induced genomic instability, suggesting that CDK5RAP3 negatively regulates double-strand break repair in the S-phase. Consistent with this cellular phenotype, analysis of transcriptomic data revealed an association between low CDK5RAP3 tumor expression and poor survival of breast cancer patients. Finally, we identified common genetic variations in the CDK5RAP3 locus as potentially associated with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Our results uncover CDK5RAP3 as a critical player in DNA repair and breast cancer outcomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biological basis of extensive pleiotropy between blood traits and cancer risk

  • Pardo-Cea, Miguel Ángel|||0000-0003-4823-6613
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Esteve, Anna|||0000-0002-1962-971X
  • Palade, Joanna
  • Espín, Roderic
  • Mateo, Francesca|||0000-0002-2342-7010
  • Alsop, Eric
  • Alorda, Marc
  • Blay, Natalia|||0000-0002-7160-8529
  • Baiges, Alexandra
  • Shabbir, Arzoo
  • Comellas, Francesc|||0000-0003-4523-0240
  • Gómez Moruno, Antonio
  • Arnan, Montserrat
  • Teule, Alex|||0000-0003-0028-7200
  • Salinas, Monica
  • Berrocal, Laura
  • Brunet, Joan|||0000-0003-1945-3512
  • Rofes, Paula|||0000-0001-6045-7879
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Conesa, Miquel
  • Rojas, Juan Jose
  • Velten, Lars
  • Fendler, Wojciech
  • Smyczynska, Urszula
  • Chowdhury, Dipanjan
  • Zeng, Yong
  • He, Housheng Hansen
  • Li, Rong
  • Van Keuren-Jensen, Kendall
  • de Cid, Rafael|||0000-0003-3579-6777
  • Pujana, Miguel Angel|||0000-0003-3222-4044
Background: The immune system has a central role in preventing carcinogenesis. Alteration of systemic immune cell levels may increase cancer risk. However, the extent to which common genetic variation influences blood traits and cancer risk remains largely undetermined. Here, we identify pleiotropic variants and predict their underlying molecular and cellular alterations. Methods: Multivariate Cox regression was used to evaluate associations between blood traits and cancer diagnosis in cases in the UK Biobank. Shared genetic variants were identified from the summary statistics of the genome-wide association studies of 27 blood traits and 27 cancer types and subtypes, applying the conditional/conjunctional false-discovery rate approach. Analysis of genomic positions, expression quantitative trait loci, enhancers, regulatory marks, functionally defined gene sets, and bulk- and single-cell expression profiles predicted the biological impact of pleiotropic variants. Plasma small RNAs were sequenced to assess association with cancer diagnosis. Results: The study identified 4093 common genetic variants, involving 1248 gene loci, that contributed to blood-cancer pleiotropism. Genomic hotspots of pleiotropism include chromosomal regions 5p15-TERT and 6p21-HLA. Genes whose products are involved in regulating telomere length are found to be enriched in pleiotropic variants. Pleiotropic gene candidates are frequently linked to transcriptional programs that regulate hematopoiesis and define progenitor cell states of immune system development. Perturbation of the myeloid lineage is indicated by pleiotropic associations with defined master regulators and cell alterations. Eosinophil count is inversely associated with cancer risk. A high frequency of pleiotropic associations is also centered on the regulation of small noncoding Y-RNAs. Predicted pleiotropic Y-RNAs show specific regulatory marks and are overabundant in the normal tissue and blood of cancer patients. Analysis of plasma small RNAs in women who developed breast cancer indicates there is an overabundance of Y-RNA preceding neoplasm diagnosis. Conclusions: This study reveals extensive pleiotropism between blood traits and cancer risk. Pleiotropism is linked to factors and processes involved in hematopoietic development and immune system function, including components of the major histocompatibility complexes, and regulators of telomere length and myeloid lineage. Deregulation of Y-RNAs is also associated with pleiotropism. Overexpression of these elements might indicate increased cancer risk.